Decibel Therapeutics, Inc. Common Stock
DBTX
DBTX was delisted on the 22nd of September, 2023.
37 hedge funds and large institutions have $59.2M invested in Decibel Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 4 closing their positions.
27% more capital invested
Capital invested by funds: $46.7M → $59.2M (+$12.6M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 38 → 37 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
+$158K |
| 2 |
AI
Acuitas Investments
Seattle,
Washington
|
+$154K |
| 3 |
B
Bailard
Foster City,
California
|
+$38.9K |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$36K |
| 5 |
BlackRock
New York
|
+$19.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$320K |
| 2 |
NM
Newtyn Management
New York
|
-$197K |
| 3 |
MAM
Marquette Asset Management
Minneapolis,
Minnesota
|
-$59.7K |
| 4 |
Morgan Stanley
New York
|
-$35K |
| 5 |
JP Morgan Chase
New York
|
-$31.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Baird Financial Group
Milwaukee,
Wisconsin
| $57.4K | – | – | – |
|
|
LCM
27
Laurion Capital Management
New York
| $46.2K | – | – | – |
|
28
Barclays
London,
United Kingdom
| $41.8K | – | – | – |
|
|
B
29
Bailard
Foster City,
California
| $40.8K | +$38.9K | +10,600 | New |
|
|
FHA
30
Flagship Harbor Advisors
Boston,
Massachusetts
| $38.9K | – | – | – |
|
|
31
Morgan Stanley
New York
| $25.4K | -$35K | -9,526 | -59% |
|
32
Lazard Asset Management
New York
| $15K | +$14.6K | +3,970 | New |
|
|
TRCT
33
Tower Research Capital (TRC)
New York
| $11K | -$8.17K | -2,226 | -44% |
|
34
UBS Group
Zurich,
Switzerland
| $6.68K | +$6.2K | +1,689 | +3,672% |
|
35
Royal Bank of Canada
Toronto,
Ontario, Canada
| $3K | -$1.16K | -316 | -30% |
|
36
Wells Fargo
San Francisco,
California
| $362 | +$15 | +4 | +4% |
|
|
CSS
37
Cubist Systematic Strategies
Stamford,
Connecticut
| $39 | -$2.06K | -561 | -98% |
|
|
MAM
38
Marquette Asset Management
Minneapolis,
Minnesota
| – | -$59.7K | -19,783 | Closed |
|
39
Bank of America
Charlotte,
North Carolina
| – | -$2.27K | -750 | Closed |
|
DBTX Hedge Fund Activity: Q2 2023 in Review
37 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Decibel Therapeutics, Inc. Common Stock (DBTX) for Q2 2023, worth a combined $59.2M — up 27% from $46.7M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of DBTX and 3 opened new positions — a net loss of 1 holder — while 9 trimmed existing stakes and 6 added.
The largest buyer was Neuberger Berman Group, adding an estimated $158K. The largest seller was Millennium Management, cutting an estimated $320K.
- 37 institutional investors held Decibel Therapeutics, Inc. Common Stock (DBTX) as of Q2 2023, down from 38 in Q1 2023.
- Funds reported $59.2M of Decibel Therapeutics, Inc. Common Stock stock for Q2 2023, up 27% quarter-over-quarter.
- 3 funds opened new Decibel Therapeutics, Inc. Common Stock positions in Q2 2023 and 4 closed out, a net change of -1 holder.
- The largest Decibel Therapeutics, Inc. Common Stock buyer in Q2 2023 was Neuberger Berman Group, an estimated $158K added.
- The largest Decibel Therapeutics, Inc. Common Stock seller in Q2 2023 was Millennium Management, an estimated $320K sold.
Based on aggregated 13F filings for Q2 2023.